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ABSTRACT
Purpose: this study aimed to determine the epidemiological, technical and clinical data
of transjugular intrahepatic portosystemic shunt (TIPS) performed by Interventional
Radiology departments in Spain. Furthermore, the total number of TIPS carried out in
Spain was determined and compared with other countries.
Material and methods: a retrospective study was performed with the approval of the
Ethical Committee of the Spanish Society of Interventional Radiology (SERVEI). A
survey was performed with 31 items (demographic, technical and clinical data) for data
acquisition on the current status of TIPS in Spain. The survey was sent to the 49
hospitals that SERVEI included in a previous registry with data of TIPS performed in
Spain in 2016.
Results: of the 49 centers surveyed, 33 (67.35 %) replied to the survey. These centers
had completed 265 of the 415 TIPS that year in Spain. The most frequent indication
was upper GI bleeding from gastroesophageal varices, which accounted for 144
(54.33 %); 62.26 % of the TIPS were performed urgently and 37.7 % on a scheduled
basis. The technical success was 89.16 ± 20.9 %, with a rebleeding rate of 17.9 %. Sixty-
nine patients (26.03 %) presented complications, 19.62 % of them minor and 6.41 %
major. The 30-day mortality related to the disease was 14.33 %, while mortality at one
year was 18.49 %.
Conclusion: notably in our study, the complications of TIPS did not show a clear
relationship with the number of procedures performed. With regard to other countries
like the United States and France, the number of TIPS in Spain per million inhabitants is
currently substantially lower. There were no significant changes compared to the
number completed in 2013.
Keywords: Transjugular intrahepatic portosystemic shunt (TIPS). TIPS Spain.
INTRODUCTION
Intrahepatic portosystemic shunt by a transjugular approach (TIPS) is an important
minimally invasive procedure for complications arising from liver cirrhosis (portal
hypertension and/or ascites refractory to treatment). Since its introduction by GM
Richter 29 years ago (1), it has been universally accepted as an effective treatment for
liver cirrhosis complications such as gastroesophageal varices bleeding and refractory
ascites (2). More than 2,387 articles found using the MESH term “Portosystemic Shunt,
Intrahepatic Transjugular” corroborate its relevance and scientific interest. Manuel
Maynar (3) introduced this procedure in Spain in 1991 and since then, more than 55
scientific articles regarding TIPS have been published. However, most of the published
articles (40, 72.2 %) correspond to a group of gastroenterologists who perform this
technique (4).
The main indications of TIPS, according to the guidelines of societies such as the
Society of Interventional Radiology (SIR) and the American Association for the study of
Liver Diseases (AASLD), are recurrent gastroesophageal varices bleeding and cirrhotic
ascites refractory to medical treatment (5). Other indications are hepatorenal
syndrome, recurrent hydrothorax in cirrhotic patients, Budd-Chiari disease, as well as
sinusoidal occlusion syndrome in hematopoietic transplants (SOS). The publication by
García-Pagán et al. (7) in NEJM in 2010 increased the number of TIPS performed, due
to the recommendation of the early performance of TIPS in cirrhotic patients with
gastroesophageal varices bleeding. However, it is not clear if this publication
conditioned the increase in the number of TIPS in Spain.
There are many international consensus and different recommendations for the
indication of TIPS within each country. However, there are few scientific publications
that indicate the number of TIPS performed in each country or each region (6,8,9). The
Spanish Society of Vascular and Interventional Radiology (SERVEI) is aware of the
number of TIPS performed annually through the records of its medical activity.
However, it lacks data on indications, complications, follow-up and mortality (10).
There are a total of 222 hospitals in Spain, of which 110 (49 %) have an Interventional
Radiology specialized team (IRst). The vast majority of hospitals are tertiary level (79,
71.8 %) and the rest are second-level health care hospitals (21, 28.2 %). All of these
hospitals serve a population of around 46.48 million inhabitants.
MATERIAL AND METHODS
Data source
We analyzed the data reported in the annual registry of SERVEI in the year 2016 of the
110 hospitals with an IRst in Spain. A total of 87 centers (79.09 %) answered their
medical activity registry in 2016 and 49 (44.54 %) hospitals declared that they had the
TIPS procedure included in their portfolio. According to this registry, 415 TIPS were
performed during 2016. A survey was sent electronically to all 49 centers with specific
questions related to the TIPS performed in their hospital within the time studied. A
confidentiality agreement and handling of clinical data of each patient were requested
from all IRst through the Spanish Society of IR (SERVEI). All patients who underwent
TIPS had signed an informed consent.
Study design
This retrospective study was approved by the SERVEI Ethics Committee to publish the
data recorded in the SERVEI 2016 registry report (23-00-2019-SERVEI16). The article
was written following the guidelines of the STROBE statement for observational
studies (11).
Settings and participants
From July 1st, 2018 to February 28th, 2019, the 49 centers that had reported TIPS during
2016 were sent an electronic survey via e-mail. This survey (Fig. 1) collected the clinical
and technical data related to the patients who underwent TIPS during the period from
January 1st, 2016 to December 31st, 2016, with at least one year of clinical follow-up.
The data came from the database of each hospital and their medical records. All the
surveys were analyzed using spreadsheets and the SPSS statistical program version
21.0 (IBM Corp, Armonk, New York).
Survey and variables
Thirty-one questions were asked in the survey (Fig. 1): type of healthcare hospital
(primary, secondary or tertiary), whether the hospital had a relationship with the
university, patient data (age, sex), assisted population, the total number of TIPS
performed, the indication for the TIPS, Child-Pugh score, average MELD score, TIPS
performed urgently or scheduled, technical success, complications, deaths at 30 days
and one year, transplant patients and special comments regarding technical
difficulties.
The inclusion criteria for the study were as follows: TIPS performed during the period
from January 1st, 2016 to December 31st, 2016 by a Spanish interventional radiologist (a
member of SERVEI), > 18 years of age and at least one year of follow-up. The
procedure was defined as a technical success when the TIPS was accomplished without
fatal complications and a reduction below the critical threshold (12 mmHg). Only those
patients whose cause of death was directly or indirectly related to their liver disease
were included as deceased at 30 days and one year. Patients who died due to other
causes (neoplasms, etc.) were not considered. All centers were classified according to
the number of procedures performed: very low (1-4 TIPSS/year), low (5-9 TIPS/year),
medium (10-19 TIPSS/year), high (20-29 TIPS/year) and very high (> 30 TIPS/year). This
was compared with the number of deaths at 30 days related to their initial pathology
(liver disease) to determine if there was a statistical correlation. The complications
were classified by SIR classification, which divides them into major and minor and was
subdivided into six subgroups (A-F) (12) (Table 2).
Statistical analysis
All statistical analyses were performed using a computer software program for
statistical analyses with SPSS (IBM Corp. Released 2012, IBM SPSS Statistics for
Macintosh, version 21.0. Armonk, NY: IBM Corp). All data were expressed as the mean
and SD for qualitative variables and categorical data were expressed as percentages. A
p value of < 0.05 was considered as statistically significant.
RESULTS
A total of 33 centers (67.35 %) answered the survey of the 49 included hospitals. These
are the most important and representative in Spain, with an average of 740.42 ±
439.24 beds per hospital (range 130-2,521 beds) and an average assisted population of
367,363.64 ± 193,708.83 inhabitants per hospital. Most of the hospitals were tertiary
health care level, except for three (3/33; 9.1 %) and the majority were university
hospitals except for two (2/33; 4.08 %). Four hospitals (4/33; 12.12 %) did not perform
any TIPS in 2016 despite having TIPS accredited in their work portfolio. Out of a total of
415 TIPS performed in Spain in 2016, the hospitals that answered the survey had only
performed a total of 265 with an average of 8.03 ± 7.09 (range 0-25) per hospital.
These 265 TIPS were performed in 265 patients, 199/265 (75.09 %) were male and
66/265 (24.90 %) were female, with an average age of 50.13 ± 19.62 years (range 42-
67 years). According to the Child-Pugh classification, patients were classified as A:
44/265 (16.60 %), B: 188/265 (70.94 %) and C: 33/265 (12.45 %). The average MELD
score was 13.67 ± 2.2 points (range 10.9-17.2). A chronic portal thrombosis had been
diagnosed in 9/265 (3.39 %) patients before performing the TIPS.
The main clinical departments that sent the patients for TIPS were the Gastrointestinal
and Liver departments (48.5 %) and the Intensive Care units (39.4 %). The most
frequent indication was bleeding from gastroesophageal varices in 144 cases
(54.33 %), followed by prophylaxis of bleeding in 55 (20.75 %) and refractory ascites to
treatment in 53 patients (20.75 %). Other indications were Budd-Chiari syndrome in
eleven cases (4.15 %) and hepatorenal syndrome in three patients (1.13 %). A total of
165 (62.26 %) of the TIPS were performed urgently, while 100 (37.7 %) were
scheduled. Technical success was reached in 89.16 ± 20.9 % (range 50-100 %) of the
patients. In this group, there was rebleeding during the follow-up in 41 patients
(17.9 %). Twenty-one IRst groups (72.4 %) achieved an average technical success in
their procedures in 95-100 % of the cases. Sixty-nine patients (26.03 %) presented
complications related to the procedure, of which 52/265 (19.62 %) were minor and
17/265 (6.41 %) were major. The mortality related to the disease at 30 days was
38/265 (14.33 %) and 49/265 (18.49 %) at one year (Fig. 2).
The number of TIPS performed each year by category were as follows: VL: 35 hospitals
(13.20 %), L: 59 (22.26 %), M: ​​103 (38.86 %) and H: 68 (25.66 %). There were no
hospitals in the VH category. The overall complications and mortality by hospital
category are summarized in table 1.
DISCUSSION
Several studies have shown that performing early TIPS improves mortality and reduces
rebleeding and hospital stay in patients with decompensated cirrhosis and bleeding
secondary to gastroesophageal varices (9,13-15). Based on these data, early TIPS
should be performed in patients diagnosed with bleeding due to gastroesophageal
varices that meet the previously mentioned conditions. This hypothesis is reinforced
by the studies of García-Pagán et al. (8,9), in which the pharmacological treatment +
endoscopic ligation was compared with the early performance of TIPS for the control
of bleeding, bleeding at six months and one-year survival. In these studies, survival was
more than 20 % higher in patients with early TIPS (61 % versus 86 %). Furthermore, the
control of bleeding (13.2 %) and rebleeding (30.0 %) showed a clear benefit of an early
TIPS at one and two years. There are currently no epidemiological data supporting the
increase or decrease in the number of TIPS in the world or Spain after this publication
(8,12,17). According to the SERVEI activity registry, 415 TIPS were performed in 49
centers (ratio per hospital, 8.4 TIPS/year in 2016) in Spain during 2016. The number of
TIPS performed in 2013 was compared using the same registry and there was no
significant increase (ratio of 7.9 vs 8.4 TIPS/year). There are no data available regarding
the stabilization, increase or decrease in the number of TIPS in Spain. In comparison to
other countries in the same period, the rate was 3.3 per million inhabitants/year in
Spain and 17.2 per million/year in the United States. With regard to Europe, the rate
was 87.2 per million/year in France (18).
According to Sarwar A et al., the performance of few TIPS procedures in a center could
increase the mortality and complications of patients undergoing TIPS (19). A total of
57.5 % of the centers that responded to the survey performed between one and nine
TIPS per year (VL, L). In this group, the total number of complications was higher
compared to the group of centers that were classified as high or very high. These
complications are reduced with the experience of the team and the number of TIPS
performed. It is unwise to establish a threshold, since most published series have
hundreds of patients that could not be achieved by a single hospital. A threshold of
5 % has been established for major complications (20).
Of the 49 Spanish centers that had performed TIPS during 2016, only 33 (67.34 %)
answered the survey with a combined total of 265 TIPS. Almost three-quarters of the
TIPS (199/265) (75.9 %) were performed as a prophylaxis in patients with bleeding due
to gastroesophageal varices. It is not known if these TIPS were performed as an early
or rescue procedure. The vast majority of patients (73.8 %) were Child-Pugh B stage
and the mean MELD score was 14.3 ± 5.37 points. Ascites refractory to treatment was
the second indication in 53/265 (20 %) of cases, which means that these two
indications accounted for 96 % of all TIPS. These data regarding indications for TIPS
differ from other countries, as is the case in the United States, where these two
indications only accounted for 66.7 % of all the TIPS (18).
Intraoperative mortality during TIPS is infrequent and there are few reported cases in
this regard (21). In the present study, no intraoperative mortality was observed, with a
small percentage of major complications (6 %). However, it must be highlighted that
type D cases required therapeutic measures and a prolonged hospitalization. In
addition, 16.6 % of minor complications did not require special therapeutic measures
and the 30-day mortality was greater in the very low and low categories (p < 0.005). In
Spain, the number of deaths per year during the acute episode of gastroesophageal
variceal bleeding is unknown and there are no clear recommendations for the
indication of TIPS in different hospitals. Before bleeding due to gastroesophageal
varices, various pharmacological and endoscopic measures are performed until the
gastroenterologist or the interventionist indicates a TIPS (in general, the patient has a
more severe clinical situation that modifies the Child-Pugh score). In Spain, to our
knowledge, early TIPS is not performed in the majority of centers, with the exception
of the García-Pagán group (16). Thus, in light of current publications, early TIPS could
improve survival in Child B and C patients with less than 14 points.
In our study, there was no evidence of the relationship between TIPS and liver
transplantation; 11.6 % (31) of the patients received a transplant in the first year after
TIPS compared to 1,159 patients who underwent a transplant in Spain during 2016.
Thus, 2.8 % of all transplants had a TIPS. Larger studies are needed to determine
whether TIPS could be a safe pre-transplant procedure.
The study has some limitations, one is that only 67.34 % (33/49) of the centers that
perform TIPS answered the survey. On the other hand, it was a retrospective
multicentric study with some heterogeneity in the data and clinical practice, which had
to be standardized.
In conclusion, with the present data, there is no evidence to indicate whether
sufficient TIPS are performed in Spain. The number of TIPS per million inhabitants is
lower than in other countries such as the United States and France. However, despite
having a lower number of TIPS, mortality and major complications in Spain are
comparable to published data (13,19,22,23). More studies are needed to be able to
answer these questions.
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Table 1. Major and minor complications classified by categories, limited by the number of TIPS/year
2
Data collected between January 1st, 2016 and December 31st, 2016. VL: very low (1-4 TIPS/year); L: low (5-9 TIPS/year); M: medium (10-19
TIPS/year); H: high (20-29 TIPS/year); VH: very high (> 30 TIPS/year).
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A No AE, no therapy
B
No AE, nominal therapy, includes overnight
admission for observation only
Major complications
C
Requires therapy, minor hospitalization (< 48
h)
D
Requires major therapy, unplanned increase






Fig. 1. Survey sent to 49 hospitals about the aspects related to TIPS.
3
Fig. 2. Major and minor complications according to the SIR classification in the SERVEI
2016 registry.
